Safety Immunogenicity Study of MT-2766 in Japanese Adults（COVID-19）

Clinical trial NCT05065619 · TERMINATED

Trial details

NCT number: NCT05065619
Sponsor: Medicago
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

SARS-CoV-2 Infection

Start date: 2021-10-02
Primary completion: 2022-03-12
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.